Inspire Medical Systems (INSP) Tops Q2 EPS by 8c; Offers FY22 Revenue Guidance

Inspire Medical Systems (NYSE: INSP) reported Q2 EPS of ($0.53), $0.08 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $91.4 million versus the consensus estimate of $78.42 million.

GUIDANCE:

Inspire Medical Systems sees FY2022 revenue of $354-362 million, versus the consensus of $342.5 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• C.H. Robinson acquires DeSpir Logistics for $75 million
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM